Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S512000, C548S466000, C548S467000, C546S276700, C546S200000, C514S323000, C514S339000
Reexamination Certificate
active
07094800
ABSTRACT:
The invention relates to compounds of the formula Iin which the radicals have the meanings stated in the text, their stereoisomeric forms, and their physiologically tolerated salts, physiologically functional derivatives and process for their preparation.The compounds are suitable for the treatment of disorders of metabolism, such as type 2 diabetes.
REFERENCES:
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 6380357 (2002-04-01), Hermeling et al.
patent: 6624185 (2003-09-01), Glombik et al.
patent: 6884812 (2005-04-01), Glombik et al.
patent: 10142734 (2003-03-01), None
patent: 0485219 (1992-05-01), None
patent: 0462884 (1993-06-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 99/31507 (1999-06-01), None
patent: WO 00/34331 (2000-06-01), None
patent: WO 00/34332 (2000-06-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/04156 (2001-01-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
Boyd et al, “y-Lactam Analogues of Carbapenems,” Tetrahedron Letters, vol. 27, No. 30, pp. 3457-3460 (1986).
Aicher, et al., Substituted Tetrahydroprrolo[2,1-b]Oxazol-5(6H)-Ones and Tetrahydropyrrolo[2,1-b]Thiazol-5(6H)-Ones as Hypoglycemic Agents1, J. Med. Chem. (1998) vol. 41, pp. 4556-4566.
Asakawa, A., et al., Cocaine-Amphetamine-Regulated Transcript Infuences Energy Metabolism, Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research, 2001, vol. 33(9), pp. 554-558.
Lee Daniel W et al., Leptin agonists as a potential approach to the treatment of obestiy, Drugs of the Future, 2001, vol. 26(9), pp. 673-881.
Okada Hiroshi et al., Synthesis and Antitumor Activities of Prodrugs of Benzoylphemylureas, Chem. Pharm. Bull., 1994, vol. 42(1), pp. 57-61.
Salvador Javier et al., Perspectives in the therapeutic use of leptin, Expert Opinion Pharmacotherapy 2001, 2(10), 1615-1622.
Tyle, Praveen, Iontophoretic Devices for Drug Delivery, Phamaceutical Research, vol. 3, No. 6, 1986 pp. 318-326.
Zunft, H. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Therapy, 2001, vol. 18(5), pp. 230-236.
Buning Christian
Gaul Holger
Jaehne Gerhard
Schoenafinger Karl
Tschank Georg
Freistein Andrew B.
Kurys Barbara E.
Sanofi-Aventis Deutschland GmbH
Solola Taofiq
LandOfFree
Cyanopyrrolidides, process for their preparation and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyanopyrrolidides, process for their preparation and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanopyrrolidides, process for their preparation and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3668355